Fidelity Disruptive Medicine ETF Rating $23.82 -0.36 (-1.49%) Closing price 07/11/2025 03:58 PM EasternExtended Trading$23.81 -0.01 (-0.04%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Fidelity Disruptive Medicine ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FMED Aggregate RatingModerate Buy 2.83Holdings in FMED have an aggregate rating of Moderate Buy based on 688 analyst ratings issued in the past year covering 46 companies (85.5% of the portfolio).FMED Aggregate Price Target$23.82High Prediction$23.82Average Prediction$23.82Low Prediction$23.82Holdings in FMED have an aggregate price target of $23.82 and a range of $23.82 to $23.82 covering 46 companies (85.5% of the portfolio).FMED Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy12 Buy rating(s)Moderate Buy30 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Fidelity Disruptive Medicine ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 46 FMED Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.47%BSXBoston Scientific$103.16-0.7%4.6489 of 5 stars3.13$116.09 12.5%24Trending News3.98%ALNYAlnylam Pharmaceuticals$314.94-2.4%4.1734 of 5 stars2.80$345.70 9.8%25Positive NewsAnalyst Forecast3.60%VEEVVeeva Systems$275.82-2.1%3.8937 of 5 stars2.50$271.04 -1.7%24Positive NewsInsider Trade3.51%DHRDanaher$204.80-0.3%4.8907 of 5 stars2.85$248.43 21.3%20Positive NewsAnalyst Upgrade3.39%PODDInsulet$289.32-2.7%4.6052 of 5 stars2.83$321.00 10.9%18Positive News3.29%WAYWaystar$37.41-0.6%4.0922 of 5 stars3.14$42.23 12.9%14Insider Trade3.27%ISRGIntuitive Surgical$512.06-2.7%4.6881 of 5 stars2.70$592.59 15.7%20Positive News3.11%ARGXargenex$560.24-0.5%4.429 of 5 stars3.10$728.06 30.0%21Positive News3.09%EXASExact Sciences$51.91-2.6%4.7703 of 5 stars2.95$70.50 35.8%222.95%PENPenumbra$237.37-2.7%4.7808 of 5 stars2.88$305.07 28.5%17Insider Trade2.84%LEGNLegend Biotech$38.96-1.9%3.3876 of 5 stars2.91$72.70 86.6%112.67%MASIMasimo$162.99-2.0%4.1812 of 5 stars2.83$191.60 17.6%62.62%UNHUnitedHealth Group$303.81+1.4%4.997 of 5 stars2.60$415.00 36.6%25Trending NewsUpcoming Earnings2.57%SYKStryker$389.24-1.4%4.8003 of 5 stars2.79$428.55 10.1%19Positive News2.46%EWEdwards Lifesciences$78.07-0.9%4.3741 of 5 stars2.40$80.40 3.0%25Positive News1.88%LLYEli Lilly and Company$793.34+0.3%4.9834 of 5 stars2.75$1,012.56 27.6%20Trending NewsAnalyst ForecastAnalyst Revision1.87%DXCMDexCom$83.37-2.4%4.7898 of 5 stars2.95$98.50 18.1%22Positive News1.75%LFSTLifeStance Health Group$4.51-4.7%3.0847 of 5 stars2.83$8.50 88.5%6High Trading Volume1.69%INSPInspire Medical Systems$130.48-6.3%4.8825 of 5 stars2.73$211.91 62.4%11Positive NewsAnalyst Upgrade1.64%REGNRegeneron Pharmaceuticals$567.74+1.4%4.8305 of 5 stars2.80$814.57 43.5%25Trending NewsAnalyst Forecast1.57%ZLABZai Lab$32.73-4.0%3.3288 of 5 stars2.80$54.28 65.8%51.55%RMDResMed$254.15-1.5%4.1629 of 5 stars2.64$259.33 2.0%14Positive News1.54%TMOThermo Fisher Scientific$435.02+1.0%4.991 of 5 stars2.80$600.30 38.0%20Trending NewsDividend AnnouncementAnalyst UpgradeAnalyst Revision1.49%PRVAPrivia Health Group$20.47-3.0%4.4962 of 5 stars3.00$28.38 38.7%131.47%DOCSDoximity$60.26+0.3%2.2988 of 5 stars2.64$64.42 6.9%22Positive NewsInsider Trade1.41%PHRPhreesia$26.74-6.7%3.5194 of 5 stars3.00$31.64 18.3%111.41%MRUSMerus$54.50-1.1%1.9208 of 5 stars3.14$84.64 55.3%14Analyst UpgradeInsider Trade1.37%AGLAgilon Health$2.23-3.5%2.3855 of 5 stars2.17$4.71 111.4%181.26%ASNDAscendis Pharma A/S$174.96-0.9%3.731 of 5 stars3.00$223.07 27.5%15Positive NewsAnalyst Forecast1.21%GKOSGlaukos$103.68-2.7%4.3467 of 5 stars2.75$134.67 29.9%121.09%PRCTPROCEPT BioRobotics$56.65-4.3%2.3 of 5 stars2.78$87.50 54.5%9Analyst Downgrade1.08%MLTXMoonLake Immunotherapeutics$49.00+0.2%1.7104 of 5 stars3.00$74.50 52.0%71.06%CRNXCrinetics Pharmaceuticals$31.93-0.2%3.4696 of 5 stars2.80$69.50 117.7%101.03%ALGNAlign Technology$202.28-1.1%4.6249 of 5 stars2.67$242.92 20.1%15Positive News0.98%XENEXenon Pharmaceuticals$32.21-2.3%3.4619 of 5 stars3.00$54.82 70.2%120.88%BRKRBruker$43.79+0.5%4.8539 of 5 stars2.40$52.89 20.8%100.81%CYTKCytokinetics$37.01+1.1%3.9745 of 5 stars2.93$70.92 91.6%150.80%VCYTVeracyte$27.08-1.6%3.5814 of 5 stars2.70$40.90 51.0%100.80%PCVXVaxcyte$35.93-0.9%1.8293 of 5 stars3.10$136.50 279.9%10Positive News0.79%IRTCiRhythm Technologies$135.94+0.9%1.0431 of 5 stars2.90$138.60 2.0%100.79%COGTCogent Biosciences$10.98+1.2%3.1757 of 5 stars2.82$18.00 63.9%11Trending NewsHigh Trading Volume0.72%WSTWest Pharmaceutical Services$226.93-1.0%4.762 of 5 stars2.89$320.00 41.0%90.72%RGENRepligen$130.19-2.8%4.6008 of 5 stars2.69$170.75 31.2%13Positive News0.70%OMOutset Medical$19.39-5.9%1.4605 of 5 stars3.00$27.00 39.2%3Gap Down0.68%TXG10x Genomics$12.80+1.4%4.5096 of 5 stars2.46$14.13 10.4%13Analyst Forecast0.65%JANXJanux Therapeutics$25.15-1.8%1.908 of 5 stars3.08$91.89 265.4%12Analyst Forecast This page (NASDAQ:FMED) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fidelity Disruptive Medicine ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Fidelity Disruptive Medicine ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.